Latest filing published 13 Feb 2025 for Senores Pharmaceuticals Limited, €61. Read the official filing
All filings by Sanjay Shaileshbhai Majmudar on record concern Senores Pharmaceuticals Limited. We count 24 filings, every one of them for a trade on 13 February 2025.
On the market, this insider has only ever bought: 24 purchases, €18k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €312. Clusters matter here: 22 out of 22 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 13 February 2025, the filings show an open-market purchase worth €61 in Senores Pharmaceuticals Limited. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations